Inventor · disambiguated record
François Bénard
Also filed as: BENARD FRANCOIS · BÉNARD FRANCOIS · BÉNARD FRANÇOIS
12 granted patents·17 pending applications·50 citations·filing 1996–2025
87Inventor score
Files withPROVINCIAL HEALTH SERVICES AUTHORITY17UNIV BRITISH COLUMBIA4BRITISH COLUMBIA CANCER AGENCY BRANCH3ADMARE THERAPEUTICS SOC2PHILIPS CORP1
Top patents by PatentIndex Score
29 records- 0193US11395857B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Jul 26, 2022·3 cites·33 claims
- 0288US11884714B2Cyclic peptide analogs of melanocortin and amanitin and methods of making suchUNIV BRITISH COLUMBIA·Filed 2022·Granted Jan 30, 2024·1 cites·1 claims
- 0387US11396535B2Cyclic peptide analogs of melanocortin and amanitin and methods of making suchUNIV BRITISH COLUMBIA·Filed 2020·Granted Jul 26, 2022·2 cites·1 claims
- 0486US10150804B2Compositions and methods for imaging cancerBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2015·Granted Dec 11, 2018·6 cites·19 claims
- 0585US11504441B2Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Nov 22, 2022·1 cites·20 claims
- 0680US10882871B218/19F-labelled compounds which target the prostate specific membrane antigenBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Granted Jan 5, 2021·3 cites·20 claims
- 0778US2024350681A1Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 0876US12246076B2Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Granted Mar 11, 2025·0 cites·14 claims
- 0974US2024342321A1Novel cxcr4-targeting compoundsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 1072US12427209B2Dual mode 18F-labelled theranostic compounds and uses thereofPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted Sep 30, 2025·1 cites·5 claims
- 1169US2023348535A1Radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1268US11992537B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted May 28, 2024·0 cites·20 claims
- 1362US2024100203A1Novel cxcr4-targeting compoundsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Application pending·0 cites
- 1461US2025161501A1Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related DisordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1560US10039846B2Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disordersBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2013·Granted Aug 7, 2018·1 cites·11 claims
- 1660US5794117ACable television network with upstream channel specialized for sending upstream information signalsPHILIPS CORP·Filed 1996·Granted Aug 11, 1998·32 cites·15 claims
- 1759US2023114807A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2022·Application pending·0 cites
- 1859US2025242064A1Cxcr4-targeting compounds, and methods of making and using the samePROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1957US2025195702A1Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2025·Application pending·0 cites
- 2052US2025186627A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 2149US2022218852A1Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Application pending·0 cites
- 2247US12472272B2Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Granted Nov 18, 2025·0 cites·40 claims
- 2347US2024309070A1Anti-vaccinia virus antigen antibodies and related compositions and methodsADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 2446US2023027475A1Anti-oncolytic virus antigen antibodies and methods of using sameADMARE THERAPEUTICS SOC·Filed 2020·Application pending·0 cites
- 2546US2023270892A1Chelator compositions for radiometals and methods of using sameTRIUMF INC·Filed 2021·Application pending·0 cites
- 2645US2024018110A1Radiolabeled compounds targeting the prostate-specific membrane antigenUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 2743US2021402016A1Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Application pending·0 cites
- 2841US2022160908A1Chelators and methods of making and using sameUNIV BRITISH COLUMBIA·Filed 2019·Application pending·0 cites
- 2938US2019002785A1Lubricant composition comprising branched diesters and viscosity index improverTOTAL MARKETING SERVICES·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when François Bénard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →